<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05048602</url>
  </required_header>
  <id_info>
    <org_study_id>07082021</org_study_id>
    <nct_id>NCT05048602</nct_id>
  </id_info>
  <brief_title>Drug-induced Brugada Syndrome Research Database</brief_title>
  <official_title>Drug-induced Brugada Syndrome Research Database</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Campania &quot;Luigi Vanvitelli&quot;</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Campania &quot;Luigi Vanvitelli&quot;</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      All patients with drug-induced Brugada syndrome who are evaluated and followed at each&#xD;
      participating centers will be recorded in this register. Within this register a&#xD;
      characterization of patients and therapy will be done. Prognostic factors of adefined&#xD;
      clinical relevant endpoints will be evaluated.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 7, 2021</start_date>
  <completion_date type="Anticipated">September 7, 2025</completion_date>
  <primary_completion_date type="Anticipated">September 7, 2023</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Sudden Cardiac Death</measure>
    <time_frame>1 year</time_frame>
    <description>Unexpected death due to cardiac causes that occurs in a short time period.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Appropriate ICD Therapies</measure>
    <time_frame>1 year</time_frame>
    <description>Antitachycardia pacing therapy or shock delivered by ICD for device detected ventricular arrhythmia</description>
  </primary_outcome>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Brugada Syndrome</condition>
  <condition>Arrhythmia</condition>
  <condition>ICD</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with drug-induced Brudaga Syndrome&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  All consecutive patients with drug-induced Brugada Syndrome&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Missing Informed Consent Form&#xD;
&#xD;
          -  Missing Contact Informations for Follow up&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Vincenzo Russo, MD PhD</last_name>
    <role>Study Chair</role>
    <affiliation>University of Campania &quot;Luigi Vanvitelli&quot;</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Vincenzo Russo, MD PhD</last_name>
    <phone>+390817062355</phone>
    <email>vincenzo.russo@unicampania.it</email>
  </overall_contact>
  <location>
    <facility>
      <name>Vincenzo Russo</name>
      <address>
        <city>Naples</city>
        <state>Napoli</state>
        <zip>80131</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vincenzo Russo</last_name>
      <email>vincenzo.russo@unicampania.it</email>
    </contact>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>September 8, 2021</study_first_submitted>
  <study_first_submitted_qc>September 8, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">September 17, 2021</study_first_posted>
  <last_update_submitted>September 8, 2021</last_update_submitted>
  <last_update_submitted_qc>September 8, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 17, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Campania &quot;Luigi Vanvitelli&quot;</investigator_affiliation>
    <investigator_full_name>Vincenzo Russo</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Brugada Syndrome</mesh_term>
    <mesh_term>Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

